These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20936910)

  • 1. Interferon-γ release assay for tuberculosis screening of healthcare workers at a Korean tertiary hospital.
    Park HY; Jeon K; Suh GY; Kwon OJ; Chung DR; Yoonchang SW; Kang ES; Koh WJ
    Scand J Infect Dis; 2010 Dec; 42(11-12):943-5. PubMed ID: 20936910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial testing of Malaysian health care workers with QuantiFERON®-TB Gold In-Tube.
    Rafiza S; Rampal KG
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):163-8. PubMed ID: 22236915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis infection risk, preventive therapy care cascade and incidence of tuberculosis disease in healthcare workers at Maputo Central Hospital.
    Graves SK; Augusto O; Viegas SO; Lederer P; David C; Lee K; Hassane A; Cossa A; Amade S; Peleve S; Zindoga P; Massawo L; Torriani FJ; Nunes EA
    BMC Infect Dis; 2019 Apr; 19(1):346. PubMed ID: 31023260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers.
    Nienhaus A; Ringshausen FC; Costa JT; Schablon A; Tripodi D
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):37-48. PubMed ID: 23428101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S; Nagai H
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for latent tuberculosis infection in South Korean healthcare workers using a tuberculin skin test and whole blood interferon-gamma assay.
    Jong Lee K; Ae Kang Y; Mi Kim Y; Cho SN; Wook Moon J; Suk Park M; Kyu Kim S; Chang J; Sam Kim Y
    Scand J Infect Dis; 2010 Sep; 42(9):672-8. PubMed ID: 20482459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak.
    Lee SH; Lew WJ; Kim HJ; Lee HK; Lee YM; Cho CH; Lee EJ; Lee DY; Ryu SW; Oh SY; Kim SO; Shim TS
    Respir Med; 2010 Mar; 104(3):448-53. PubMed ID: 19879123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak.
    Lee SH; Yim JJ; Kim HJ; Shim TS; Seo HS; Cho YS; Lee HK; Lee YM; Lee EJ; Lew WJ
    Epidemiol Infect; 2012 Jun; 140(6):1028-35. PubMed ID: 21835069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of previous tuberculosis history on T-SPOT.TB® interferon-gamma release assay results.
    Kim HJ; Yoon HI; Park KU; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):510-6. PubMed ID: 21396211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort.
    Lee SW; Lee SH; Yim JJ
    Infection; 2012 Aug; 40(4):431-5. PubMed ID: 22585454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis.
    Higuchi K; Harada N; Mori T
    Respirology; 2008 May; 13(3):468-72. PubMed ID: 18399875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of prophylaxis on QuantiFERON TB-2G responses among children].
    Higuchi K; Okada K; Harada N; Mori T
    Kekkaku; 2008 Sep; 83(9):603-9. PubMed ID: 18979994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of incidence of tuberculosis infection in health-care workers using repeated interferon-gamma assays.
    Yoshiyama T; Harada N; Higuchi K; Nakajima Y; Ogata H
    Epidemiol Infect; 2009 Dec; 137(12):1691-8. PubMed ID: 19426573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of tuberculosis: epidemiology, resistance and monitoring.
    Bang D
    Dan Med Bull; 2010 Nov; 57(11):B4213. PubMed ID: 21055374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma release assays during follow-up of tuberculin skin test-positive contacts.
    Franken WP; Arend SM; Thijsen SF; Bouwman JJ; Koster BF; van Dissel JT; Bossink AW
    Int J Tuberc Lung Dis; 2008 Nov; 12(11):1286-94. PubMed ID: 18926039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States.
    LoBue PA; Enarson DA; Thoen TC
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1226-32. PubMed ID: 20843412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of tuberculosis incidents in hospital healthcare workers, England and Wales, 2005.
    Anderson C; Abubakar I; Maguire H; Sonnenberg P
    J Public Health (Oxf); 2007 Sep; 29(3):292-7. PubMed ID: 17599921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.